Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.

Kazi, Dhruv S, Christine Y Lu, Grace A Lin, Colette DeJong, Adams Dudley, Randi Chen, and Chien-Wen Tseng. 2017. “Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.”. JAMA Cardiology 2 (10): 1164-66.

Abstract

This study examines PCSK9i cost-sharing requirements for Medicare Part D plans nationwide, which insure 41 million beneficiaries.

Last updated on 09/26/2024
PubMed